[HTML][HTML] Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective
W Yu, JD Cheng - Frontiers in pharmacology, 2020 - frontiersin.org
… on the latest cellular and molecular findings of cardiovascular disease associated with
hyperuricemia and clinical data about the efficacy of ULT in patients with cardiovascular disease. …
hyperuricemia and clinical data about the efficacy of ULT in patients with cardiovascular disease. …
[HTML][HTML] RETRACTED: Cardiovascular Disease and Exercise: From Molecular Mechanisms to Clinical Applications
B Wang, L Gan, Y Deng, S Zhu, G Li, MI Nasser… - Journal of Clinical …, 2022 - mdpi.com
… process underlying the positive effects of exercise on cardiovascular health will not only …
and treating cardiovascular diseases by activating the endogenous protective mechanisms of …
and treating cardiovascular diseases by activating the endogenous protective mechanisms of …
[HTML][HTML] Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
Y Shi, H Zhang, S Huang, L Yin, F Wang… - … and Targeted Therapy, 2022 - nature.com
… diagnosis and treatment of cardiovascular diseases. Herein, … essential regulatory mechanisms
in cardiovascular diseases. … are important molecular markers of cardiovascular disease …
in cardiovascular diseases. … are important molecular markers of cardiovascular disease …
MitomiRs: new emerging microRNAs in mitochondrial dysfunction and cardiovascular disease
A Paramasivam, J Vijayashree Priyadharsini - Hypertension Research, 2020 - nature.com
… Cardiovascular diseases (CVDs) are one of the leading causes of … The molecular
mechanisms underlying the complex … Therefore, identifying the common molecular mechanisms …
mechanisms underlying the complex … Therefore, identifying the common molecular mechanisms …
[HTML][HTML] Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Y Li, Y Liu, S Liu, M Gao, W Wang, K Chen… - Signal transduction and …, 2023 - nature.com
… /microvascular lesions; pathological manifestations and molecular mechanisms of different
target organs in DPDs; common molecular mechanisms and therapeutic targets in DPDs; …
target organs in DPDs; common molecular mechanisms and therapeutic targets in DPDs; …
[HTML][HTML] … of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease
H Yanai, H Adachi, M Hakoshima… - … journal of molecular …, 2021 - mdpi.com
… Possible Molecular Mechanisms for the Development of Hyperuricemia in Metabolic Syndrome
Possible molecular mechanisms for the development of hyperuricemia in the metabolic …
Possible molecular mechanisms for the development of hyperuricemia in the metabolic …
[HTML][HTML] Inflammation and cardiovascular disease: From mechanisms to therapeutics
… the role of inflammation in atherosclerotic cardiovascular disease, discuss the predictive …
molecules such as intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule…
molecules such as intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule…
[HTML][HTML] The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
… molecular pathways of iron signalling and ferroptosis in the context of cardiovascular disease…
of ferroptosis in the treatment of cardiovascular disease and describe the current limitations …
of ferroptosis in the treatment of cardiovascular disease and describe the current limitations …
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
L Wu, AM O'Kane, H Peng, Y Bi, D Motriuk-Smith… - Biochemical …, 2020 - Elsevier
… Here we will summarize the relationship between SARS-CoV-2 and cardiovascular
diseases, and discuss possible mechanisms of action behind SARS-CoV-2 infection-induced …
diseases, and discuss possible mechanisms of action behind SARS-CoV-2 infection-induced …
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies
… of cardiovascular, metabolic, and emerging infectious diseases. Pharmacotherapies
targeting … dysfunction have potential for treatment of cardiovascular and many other diseases. …
targeting … dysfunction have potential for treatment of cardiovascular and many other diseases. …
相关搜索
- molecular mechanisms cardiovascular disease and exercise
- basic mechanisms cardiovascular disease
- ferroptosis in cardiovascular diseases
- covid 19 cardiovascular disease
- uric acid cardiovascular disease
- patients with cardiovascular disease molecular effects
- molecular mechanisms diabetic vascular diseases
- potential therapeutic targets for cardiovascular diseases
- mechanisms and advances cardiovascular disease
- cardiovascular disease morbidity and mortality
- understanding of the pathophysiology cardiovascular diseases
- dysregulation of iron metabolism cardiovascular diseases
- prevention and relief cardiovascular disease
- epigenetic modifications role in cardiovascular disease
- patients with cardiovascular disease exercise training
- clinical applications cardiovascular disease and exercise